---
title: 'NIV@Home: a pilot randomized controlled trial of in-home noninvasive ventilation
  initiation compared to a single-day admission model'
date: '2024-10-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39431591/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241022193450&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'Objective: Noninvasive ventilation (NIV) is the primary treatment for
  respiratory insufficiency in neuromuscular disease. NIV implementation is usually
  conducted within hospitals; however, in-home implementation with intensive follow-up
  is an effective alternative. This pilot study aimed to assess model feasibility,
  acceptability, and NIV usage at 12-weeks after a single visit in-home implementation
  of NIV with remote monitoring follow-up (NIV@Home) compared to an in-hospital day
  admission ...'
disable_comments: true
---
Objective: Noninvasive ventilation (NIV) is the primary treatment for respiratory insufficiency in neuromuscular disease. NIV implementation is usually conducted within hospitals; however, in-home implementation with intensive follow-up is an effective alternative. This pilot study aimed to assess model feasibility, acceptability, and NIV usage at 12-weeks after a single visit in-home implementation of NIV with remote monitoring follow-up (NIV@Home) compared to an in-hospital day admission ...